Roberto v. AbbVie Inc

CourtDistrict Court, N.D. Illinois
DecidedMarch 29, 2019
Docket1:15-cv-07085
StatusUnknown

This text of Roberto v. AbbVie Inc (Roberto v. AbbVie Inc) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Roberto v. AbbVie Inc, (N.D. Ill. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

IN RE: TESTOSTERONE ) MDL No. 2545 REPLACEMENT THERAPY ) PRODUCTS LIABILITY LITIGATION ) Case No. 14 C 1748 --------------------------------------------------------------- ) ) This document relates to: ) ) Roberto v. AbbVie, Inc., No. 15 C 7085 )

CASE MANAGEMENT ORDER NO. 147 (Memorandum Opinion and Order on Plaintiff Armando Roberto and Plaintiff Elizabeth Roberto's Motion to Vacate Dismissal in Roberto v. AbbVie, Inc., No 15 C 7085)

MATTHEW F. KENNELLY, District Judge: Plaintiffs in this multidistrict litigation (MDL) proceeding allege that they suffered either arterial cardiovascular injuries or injuries related to blood clots in the veins as a result of taking prescription testosterone replacement therapy (TRT) drugs. Defendants, including AbbVie, Inc. and affiliated entities, are manufacturers of TRT drugs. More than 7,800 individual cases have been filed in the MDL, and a little under 5,600 remain pending as of mid-March 2019. As of September 10, 2018, the Court has stayed all proceedings in the products liability cases, except as ordered by the Court, based on the parties' reports that they have finalized or are in the process of finalizing master settlement agreements. On May 11, 2018, the Court dismissed more than 150 cases with prejudice after plaintiffs in those cases—including plaintiffs Armando and Elizabeth Roberto (the Robertos)—failed to (1) comply with a case management order setting forth certain discovery obligations and (2) respond to an order to show cause why their cases should not be dismissed with prejudice due to noncompliance. Between May and September 2018, thirty-nine plaintiffs asked the Court to vacate the dismissal order and reinstate their cases. The Robertos were not part of that group. On November 15, 2018, the

Court granted thirty-seven of the motions and denied two. See In re Testosterone Replacement Therapy Prods. Liab. Litig., No. 14 C 1748, MDL No. 2545, 2018 WL 6003391 (N.D. Ill. Nov. 15, 2018) (CMO 140). On March 3, 2019, nearly ten months after the Court dismissed their case, the Robertos filed a motion asking the Court to vacate the dismissal and reinstate their case. For the following reasons, the Court denies the Robertos' motion. Legal Standard Federal Rule of Civil Procedure 60(b) "delineates six grounds upon which relief from a judgment can be granted," including "(1) mistake, inadvertence, surprise, or excusable neglect" and "(6) any other reason that justifies relief." Pearson v. Target

Corp., 893 F.3d 980, 984 (7th Cir. 2018); Fed. R. Civ. P. 60(b)(1), (6). "Rule 60 relief is limited to 'extraordinary' situations where a judgment is the inadvertent product of special circumstances and not merely [the] erroneous application[ ] of law." Kennedy v. Schneider Elec., 893 F.3d 414, 419 (7th Cir. 2018) (internal quotation marks omitted). For purposes of Rule 60(b)(1), the Seventh Circuit applies the Supreme Court's Pioneer factors in determining whether neglect (which can include negligence) is "excusable." Moje v. Fed. Hockey League, 792 F.3d 756, 759 (7th Cir. 2015). The determination whether neglect is excusable is at bottom an equitable one, taking account of all relevant circumstances surrounding the party's omission. These include ... the danger of prejudice to the [opponent], the length of the delay and its potential impact on judicial proceedings, the reason for the delay, including whether it was within the reasonable control of the movant, and whether the movant acted in good faith.

Id. (quoting Pioneer Inv. Servs. Co. v. Brunswick Assocs. L.P., 507 U.S. 380, 395 (1993)). To obtain relief under Rule 60(b)(1), "a litigant must show that both its own conduct and its lawyer's fit the category of 'excusable' neglect." Moje, 792 F.3d at 758. In other words, "a lawyer's errors are imputed to the client." Id. Rules 60(b)(1) and (6) "are mutually exclusive—Rule 60(b)(6), as a residual catchall, applies only if the other specifically enumerated rules do not." Pearson, 893 F.3d at 984. A motion for relief under Rule 60(b)(6) "must be made 'within a reasonable time.'" Arrieta v. Battaglia, 461 F.3d 861, 865 (7th Cir. 2006) (quoting Fed. R. Civ. P. 60(c)(1)). A court "may consider a wide range of factors" to determine whether "extraordinary circumstances" warrant relief under Rule 60(b)(6), including "the risk of injustice to the parties" and "the risk of undermining the public's confidence in the judicial process." Buck v. Davis, 137 S. Ct. 759, 778 (2017) (quoting Liljeberg v. Health Servs. Acquisition Corp., 486 U.S. 847, 863-64 (1988)). Background A. The Plaintiff Fact Sheet and Plaintiff Profile Form requirements

Case Management Order No. 9, which has been in effect since October 2014, requires all plaintiffs in the MDL to, among other things, complete a plaintiff fact sheet (PFS), serve it on defendants, produce to defendants all responsive, non-privileged documents in their possession that the PFS requests, and provide executed authorizations for the release of certain medical records. The PFS requests information that is highly relevant to the resolution of a plaintiff's claims. A detailed description of the type of information the PFS requests can be found in CMO 140. See 2018 WL 6003391, at *1. In December 2017, the Court issued Case Management Order No. 85 (CMO 85),

which required all plaintiffs in the MDL to supplement and update their PFS with a submission called a supplemental plaintiff profile form (PPF). The PPF also requires disclosure of information that is highly relevant to the resolution of a plaintiff's claims. See CMO 140, 2018 WL 6003391, at *1 (describing the type of information the PPF requests). The Court imposed the requirement for submission of a PPF to ensure the disclosure of relevant information needed for the preparation and litigation of the thousands of cases remaining in the MDL, as well as their ultimate resolution by settlement, ruling on a dispositive motion, remand to the appropriate transferor district, or trial before this Court. CMO 85 gave each plaintiff a reasonable time—90 days—to submit a

substantially complete PPF. CMO 85 further provided as follows: C. Should any Plaintiff fail to serve an executed PPF or if a Defendant deems a Plaintiff's PPF deficient, Defendant's counsel shall notify the Court of the alleged deficiency and the Court shall issue an "Order To Show Cause Why the Case Should Not Be Dismissed and/or Sanctions Ordered." Plaintiff's counsel shall have twenty-one (21) days to respond to said Order To Show Cause, which includes the ability to cure the alleged discovery deficiency. There shall be no imposition of a sanction for any plaintiff who cures a deficiency following issuance of an Order to Show Cause.

D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Liljeberg v. Health Services Acquisition Corp.
486 U.S. 847 (Supreme Court, 1988)
Joseph Arrieta v. Deirdre Battaglia, Warden
461 F.3d 861 (Seventh Circuit, 2006)
Kyler Moje v. Federal Hockey League LLC
792 F.3d 756 (Seventh Circuit, 2015)
Buck v. Davis
580 U.S. 100 (Supreme Court, 2017)
Bennie Kennedy v. Schneider Electric
893 F.3d 414 (Seventh Circuit, 2018)
Theodore Frank v. Target Corporation
893 F.3d 980 (Seventh Circuit, 2018)
Dzik v. Bayer Corp.
846 F.3d 211 (Seventh Circuit, 2017)
Acosta v. DT & C Global Management, LLC
874 F.3d 557 (Seventh Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Roberto v. AbbVie Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/roberto-v-abbvie-inc-ilnd-2019.